| Formulation and evaluation of periodontal in situ gel K Garala, P Joshi, M Shah, A Ramkishan, J Patel International journal of pharmaceutical investigation 3 (1), 29, 2013 | 199 | 2013 |
| Design and development of a self-nanoemulsifying drug delivery system for telmisartan for oral drug delivery J Patel, G Kevin, A Patel, M Raval, N Sheth International journal of pharmaceutical investigation 1 (2), 112, 2011 | 165 | 2011 |
| Development and characterization of transdermal therapeutics system of tramadol hydrochloride AJ Shinde, KC Garala, HN More Asian Journal of Pharmaceutics (AJP) 2 (4), 2008 | 150 | 2008 |
| Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride M Shah, YK Agrawal, K Garala, A Ramkishan Indian journal of pharmaceutical sciences 74 (5), 434, 2012 | 104 | 2012 |
| Formulation and in-vitro characterization of monolithic matrix transdermal systems using HPMC/Eudragit S 100 polymer blends KC Garala, AJ Shinde, PH Shah Int J Pharm Pharm Sci 1 (1), 108-20, 2009 | 103 | 2009 |
| Solubilization of poorly soluble drugs: A review RT Jadhav Namdeo R. Garala Kevin Shinde, Anil J. Pharmainfo. net 5 (6), 36-44, 2007 | 70* | 2007 |
| Buccoadhesive drug delivery systems: A review R Bhalodia, B Basu, K Garala, B Joshi, K Mehta International Journal of Pharma and Bio Sciences, 2010 | 56* | 2010 |
| Pharmaceutical cocrystals—a review SS Buddhadev, KC Garala Proceedings 62 (1), 14, 2021 | 50 | 2021 |
| Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis J Patel, A Dhingani, K Garala, M Raval, N Sheth Powder technology 258, 331-343, 2014 | 50 | 2014 |
| Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets J Patel, A Dhingani, K Garala, M Raval, N Sheth Drug delivery 21 (6), 412-435, 2014 | 42 | 2014 |
| Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies J Patel, G Kevin, A Patel, M Raval, N Sheth Pharmaceutical Methods 2 (1), 36-41, 2011 | 42 | 2011 |
| Formulation and evaluation of pimozide buccal mucoadhesive patches B Basu, K Garala, J Thimmasetty International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN …, 2009 | 38 | 2009 |
| Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box–Behnken experimental design KC Garala, JM Patel, AP Dhingani, AT Dharamsi International journal of pharmaceutics 452 (1-2), 135-156, 2013 | 37 | 2013 |
| Solid lipid nanoparticles: A promising tool for drug delivery system B Basu, K Garala, R Bhalodia, B Joshi, K Mehta J Pharm Res 3 (1), 84-92, 2010 | 36 | 2010 |
| Solubility of aceclofenac in polyamidoamine dendrimer solutions J Patel, K Garala, B Basu, M Raval, A Dharamsi International Journal of Pharmaceutical Investigation 1 (3), 135, 2011 | 33 | 2011 |
| Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy P Patel, K Garala, S Singh, BG Prajapati, C Chittasupho Pharmaceuticals 17 (3), 329, 2024 | 32 | 2024 |
| Quality by design (QbD) approach for developing agglomerates containing racecadotril and loperamide hydrochloride by crystallo-co-agglomeration KC Garala, JM Patel, AP Dhingani, AT Dharamsi Powder technology 247, 128-146, 2013 | 30 | 2013 |
| Preparation and evaluation of inclusion complexes of diacerein with β-cyclodextrin and hydroxypropyl β-cyclodextrin DK Batt, KC Garala Journal of Inclusion Phenomena and Macrocyclic Chemistry 77 (1), 471-481, 2013 | 24 | 2013 |
| Enhanced encapsulation of metoprolol tartrate with carbon nanotubes as adsorbent K Garala, J Patel, A Patel, A Dharamsi Applied Nanoscience 1 (4), 219-230, 2011 | 22 | 2011 |
| Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration K Garala, J Patel, A Patel, M Raval, A Dharamsi International journal of pharmaceutical investigation 2 (4), 189, 2012 | 18 | 2012 |
